Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $8.11B | $7.35B | +10.29% |
Cost of Revenue | $1.11B | $894.2M | +23.81% |
Operating Income | $-1.26B | $2.84B | -144.27% |
Net Income | $-1.45B | $2.65B | -154.65% |
EPS (Basic) | $-5.61 | $10.29 | -154.52% |
EPS (Diluted) | $-5.61 | $10.18 | -155.11% |
SG&A Expense | $1.09B | $767.5M | +41.59% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $22.24B | $21.73B | +2.37% |
Current Assets | $9.8B | $14.7B | -33.29% |
Total Liabilities | $6.61B | $5.21B | +26.78% |
Current Liabilities | $3.97B | $3.6B | +10.38% |
Stockholders' Equity | $15.63B | $16.51B | -5.34% |
Cash & Equivalents | $5.24B | $11.11B | -52.84% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-1.08B | $3.3B | -132.62% |
Investing Cash Flow | $-2.95B | $-2.26B | -30.72% |
Financing Cash Flow | $-1.1B | $-442.4M | -149.46% |
Share Buybacks | $759.2M | $278.1M | +173.00% |
D&A | $160.7M | $122.3M | +31.40% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -15.5% | 38.7% | -54.21% |
Net Margin | -17.9% | — | — |
ROE | -9.3% | — | — |
ROA | -6.5% | — | — |
Current Ratio | $2.468 | — | — |
Debt to Equity | $0.423 | — | — |
Other companies in Biotechnology